Anastrozole Risk-Reduction Persists

]]>(MedPage Today) -- SAN ANTONIO – Years after treatment had ended, women at high risk of breast cancer who were on anastrozole preventive therapy continued to be protected better than women not treated with the aromatase inhibitor, researchers...